Saratin for inhibiting platelet adhesion to collagen

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61P 9/10 (2006.01) A61M 25/00 (2006.01)

Patent

CA 2419385

Use of the polypeptide Saratin for the manufacture of a medicament having the capability to significantly decrease platelet adhesion and platelet accumulation after vascular injuries or endarterectomy. The invention furthermore relates to a novel medical use of Saratin as an inhibitor of thrombosis and intimal hyperplasia, wherein said polypeptide may be used locally as a topical agent or as a coating on, or otherwise incorporated or associated with medical devices.

L'invention concerne l'utilisation du polypeptide Saratin dans la fabrication d'un médicament capable de réduire de manière significative l'adhésion et l'accumulation des plaquettes faisant suite à des lésions vasculaires ou à une endartériectomie. L'invention concerne également une nouvelle utilisation médicale du Saratin, en tant qu'un inhibiteur de thrombose et d'hyperplasie intime, ledit polypeptide pouvant être utilisé localement comme agent topique ou comme revêtement sur des dispositifs médicaux, ou incorporé ou associé d'une façon quelconque avec ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Saratin for inhibiting platelet adhesion to collagen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Saratin for inhibiting platelet adhesion to collagen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saratin for inhibiting platelet adhesion to collagen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1804842

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.